May 10, 2024
In the Cultivation Track at Cannabis Science Conference, Bernie Lorenz, Chief Science Officer of ProKure Solutions, discussed the intriguing topic of the effects of COVID on cannabis testing methods.
In the General Session of the Cannabis Science Conference, Scheril Murray Powell, Esq. and John Calloway Jr. discussed the many ways equity ties into science in the cannabis industry.
May 09, 2024
Patrick Bird, Senior Manager of Scientific Affairs at bioMérieux, presented “Innovative Method Development to Meet the Needs for the Cannabis Industry" on the first day of Cannabis Science Conference in the Analytical Track.
As the keynote speaker for Cannabis Science Conference Spring 2024, Jamila Owens-Todd discussed the various ways to approach plant medicine and manufacturing.
April 30, 2024
Multiple sources have reported that the US Drug Enforcement Administration will move to reclassify marijuana from Schedule I to Schedule III, effectively recognizing medical uses of cannabis and its reduced potential for abuse compared with other drugs.
Here, Darwin Millard, Technical Director of CSQ, discusses the present and potential future of cannabis standards and regulations.
April 27, 2024
In this interview, Darwin Millard shares what attendees will experience in the two ASTM Subcommittee meetings he will be guiding.
April 25, 2024
In this interview, Jimmy Farrell, Standards Development Manager at ASTM International, explains the important role ASTM plays in safety and quality of the global cannabis industry.
In this interview, Jimmy Farrell explains more on this opportunity to shape standards and methods in the global cannabis industry.
In the second installment in this webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon discuss implementation of cannabis as a harm reduction agent from a clinical perspective.